Jiong Wu

Author PubWeight™ 103.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 2009 3.40
2 Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007 2.89
3 Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer. Clin Cancer Res 2009 2.13
4 Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 2006 1.99
5 Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J Biol Chem 2004 1.85
6 VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J 2005 1.63
7 Time-varying pattern of recurrence risk for Chinese breast cancer patients. Breast Cancer Res Treat 2008 1.57
8 Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat 2009 1.49
9 Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1. Mol Cell Biol 2002 1.49
10 Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 2007 1.49
11 Regulation and localization of CAS substrate domain tyrosine phosphorylation. Cell Signal 2004 1.47
12 Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J Biol Chem 2003 1.46
13 Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat 2008 1.40
14 Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics 2006 1.32
15 Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 2007 1.29
16 Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity. J Biol Chem 2006 1.27
17 The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 2008 1.23
18 Improved insulin sensitivity by calorie restriction is associated with reduction of ERK and p70S6K activities in the liver of obese Zucker rats. J Endocrinol 2009 1.20
19 Development and trends of surgical modalities for breast cancer in China: a review of 16-year data. Ann Surg Oncol 2007 1.19
20 Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinoma. Breast Cancer Res Treat 2004 1.18
21 Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. Eur J Cancer 2006 1.16
22 ERbeta exerts multiple stimulative effects on human breast carcinoma cells. Oncogene 2004 1.12
23 ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. J Cancer Res Clin Oncol 2008 1.11
24 The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 2007 1.10
25 UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res Treat 2009 1.06
26 PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell lines. J Cell Biochem 2009 1.05
27 MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer. Clin Cancer Res 2013 1.05
28 Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer. Tumori 2010 1.03
29 Identification of the functional role of AF1Q in the progression of breast cancer. Breast Cancer Res Treat 2007 1.00
30 Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients. Breast 2007 1.00
31 The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 2006 1.00
32 Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet 2009 0.98
33 Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer after five years from diagnosis: implication for extended endocrine therapy. J Clin Endocrinol Metab 2012 0.97
34 TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade. FEBS Lett 2007 0.97
35 Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy. Cancer Lett 2011 0.97
36 Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. BMC Cancer 2009 0.96
37 Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One 2012 0.96
38 Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China. Ann Surg Oncol 2012 0.96
39 A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer. FASEB J 2009 0.96
40 Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component. Ann Surg Oncol 2010 0.95
41 Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy. Oncol Rep 2010 0.94
42 USP10 inhibits genotoxic NF-κB activation by MCPIP1-facilitated deubiquitination of NEMO. EMBO J 2013 0.93
43 DNA bending by bZIP charge variants: a unified study using electrophoretic phasing and fluorescence resonance energy transfer. Biochemistry 2002 0.93
44 Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis. Cancer Sci 2009 0.93
45 Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients. Oncol Rep 2008 0.92
46 Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 2008 0.92
47 Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance. Breast Cancer Res Treat 2010 0.91
48 Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients. Breast Cancer Res Treat 2008 0.91
49 Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment. J Cancer Res Clin Oncol 2008 0.90
50 Genetic variants in GSTM3 gene within GSTM4-GSTM2-GSTM1-GSTM5-GSTM3 cluster influence breast cancer susceptibility depending on GSTM1. Breast Cancer Res Treat 2009 0.90
51 Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection. Crit Rev Oncol Hematol 2010 0.90
52 Effect of large tumor size on cancer-specific mortality in node-negative breast cancer. Mayo Clin Proc 2012 0.89
53 A straightforward but not piecewise relationship between age and lymph node status in Chinese breast cancer patients. PLoS One 2010 0.89
54 Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro. J Cancer Res Clin Oncol 2006 0.88
55 TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway. Mol Cell Biol 2011 0.88
56 The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat 2003 0.88
57 Epidural Combined with General Anesthesia versus General Anesthesia Alone in Patients Undergoing Free Flap Breast Reconstruction. Plast Reconstr Surg 2016 0.87
58 Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge. Breast Cancer Res Treat 2007 0.87
59 Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer. Int J Cancer 2014 0.86
60 Breast cancer in Chinese elderly women: pathological and clinical characteristics and factors influencing treatment patterns. Crit Rev Oncol Hematol 2009 0.86
61 Weekly paclitaxel/carboplatin/trastuzumab therapy improves pathologic complete remission in aggressive HER2-positive breast cancers, especially in luminal-B subtype, compared with a once-every-3-weeks schedule. Oncologist 2013 0.85
62 Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 2008 0.84
63 Comparative study of one-step nucleic acid amplification assay, frozen section, and touch imprint cytology for intraoperative assessment of breast sentinel lymph node in Chinese patients. Cancer Sci 2012 0.84
64 Free Flap Monitoring Using Near-Infrared Spectroscopy: A Systemic Review. Ann Plast Surg 2016 0.83
65 Morphine induces desensitization of insulin receptor signaling. Mol Cell Biol 2003 0.83
66 Basal cytokeratin expression in relation to immunohistochemical and clinical characterization in breast cancer patients with triple negative phenotype. Tumori 2009 0.83
67 Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population. World J Surg Oncol 2012 0.82
68 Are changes in circulating tumor cell (CTC) count associated with the response to neoadjuvant chemotherapy in local advanced breast cancer? A meta-analysis. Oncol Res Treat 2014 0.81
69 Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: a median follow-up of 63.4 months. BMC Cancer 2009 0.81
70 [Sentinel lymph node biopsy in breast cancer]. Zhonghua Wai Ke Za Zhi 2002 0.81
71 Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging. Ann Surg Oncol 2013 0.81
72 Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. World J Surg Oncol 2013 0.81
73 Adjuvant therapy of breast cancer with pirarubicin versus epirubicin in combination with cyclophosphamide and 5-fluorouracil. Breast J 2011 0.81
74 Efficacy and safety of docetaxel combined with oxaliplatin as a neoadjuvant chemotherapy regimen for Chinese triple-negative local advanced breast cancer patients. A prospective, open, and unicentric Phase II clinical trial. Am J Clin Oncol 2013 0.80
75 [BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases]. Zhonghua Yi Xue Za Zhi 2008 0.80
76 COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness. Tumour Biol 2013 0.80
77 Nrf2 is associated with the regulation of basal transcription activity of the BRCA1 gene. Acta Biochim Biophys Sin (Shanghai) 2013 0.80
78 Differential high-resolution melting analysis for the detection of K-ras codons 12 and 13 mutations in pancreatic cancer. Pancreas 2011 0.80
79 Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes. Exp Ther Med 2011 0.79
80 Breast conservative therapy in east part of China: a retrospective cohort study. J Cancer Res Clin Oncol 2006 0.79
81 Involvement of MyoD and c-myb in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Res Treat 2010 0.79
82 Factors associated with the misdiagnosis of sentinel lymph nodes using touch imprint cytology for early stage breast cancer. Oncol Lett 2011 0.79
83 [5589del8: the recurrent mutation of BRCA1 gene in Chinese breast cancer patients]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2007 0.79
84 Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram. Breast Cancer Res Treat 2012 0.79
85 Using peripheral blood mRNA signature to distinguish between breast cancer and benign breast disease in non-conclusive mammography patients. Cancer Biol Ther 2010 0.78
86 Risk factors for postoperative seromas in Chinese breast cancer patients. Chin Med J (Engl) 2011 0.78
87 Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas. Asian Pac J Cancer Prev 2014 0.78
88 [A study of the combination of vinorelbine and epirubicin as neoadjuvant chemotherapy regimen in the treatment of locally advanced breast cancer]. Zhonghua Wai Ke Za Zhi 2006 0.78
89 Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer. Anticancer Res 2008 0.78
90 Utility of one-step nucleic acid amplification (OSNA) assay in detecting breast cancer metastases of sentinel lymph nodes in a Chinese population. Breast Cancer 2013 0.78
91 Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients. Mol Med Rep 2012 0.78
92 Surgical management of breast cancer in China: A 15-year single-center retrospective study of 18,502 patients. Medicine (Baltimore) 2016 0.77
93 [Peripheral blood mutated p53 DNA and its clinical value in human breast cancer]. Zhonghua Zhong Liu Za Zhi 2003 0.77
94 Localization and evaluation of sentinel lymph node in breast cancer from computed tomographic lymphography. J Comput Assist Tomogr 2011 0.77
95 [Surgical management of early breast cancer]. Zhonghua Zhong Liu Za Zhi 2007 0.77
96 PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells. Acta Biochim Biophys Sin (Shanghai) 2011 0.77
97 The evaluation and optimization of intraoperative touch imprint cytology for sentinel lymph nodes in early-stage breast cancer in China. World J Surg 2010 0.76
98 [Retrospective analysis of trastuzumab treatment in 141 patients with Her-2 positive breast cancer]. Zhonghua Zhong Liu Za Zhi 2010 0.76
99 [Analysis of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives]. Zhonghua Zhong Liu Za Zhi 2004 0.76
100 Clinical significance of aromatase protein expression in axillary node negative breast cancer. J Cancer Res Clin Oncol 2007 0.76
101 [Mucosa advancement flap anoplasty in treatment of chronic anal fissures: a prospective, multicenter, randomized controlled trial]. Zhong Xi Yi Jie He Xue Bao 2011 0.76
102 Association of HER-2 copy number and HER-2/CEP-17 ratio with neoadjuvant taxane-containing chemotherapy sensitivity in locally advanced breast cancer. Oncologist 2012 0.75
103 Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy. Medicine (Baltimore) 2016 0.75
104 Determination of carbohydrate-deficient transferrin in a Han Chinese population. BMC Biochem 2014 0.75
105 Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population. Medicine (Baltimore) 2015 0.75
106 Clinicopathological features of breast cancer patients with nipple discharge. Mol Med Rep 2010 0.75
107 [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors]. Ai Zheng 2007 0.75
108 [Biological significance of E-cadherin in an inflammatory breast carcinoma cell line]. Zhonghua Zhong Liu Za Zhi 2006 0.75
109 [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]. Zhonghua Zhong Liu Za Zhi 2006 0.75
110 [Clinico-pathological features of ER+/PR+ and ER+/PR- breast tumors: a comparative study of 5211 cases]. Zhonghua Yi Xue Za Zhi 2007 0.75
111 Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer. Asian Pac J Cancer Prev 2015 0.75
112 Unlabeled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in pancreatic adenocarcinoma tissues. Clin Chem Lab Med 2012 0.75
113 [Evaluation of intraoperative molecular assay in sentinel lymph node biopsy from breast cancer patients]. Zhonghua Bing Li Xue Za Zhi 2010 0.75
114 [Lymphoscintigraphy in sentinel lymph node biopsy of breast cancer]. Zhonghua Zhong Liu Za Zhi 2002 0.75
115 A novel technique for localization of sentinel lymph node in breast cancer patients based on computed tomographic lymphography. Breast J 2011 0.75
116 [Germline mutations of TP53 gene among Chinese families with high risk for breast cancer]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2015 0.75
117 [Clinicopathological significance of aromatase expression in breast cancers]. Zhonghua Wai Ke Za Zhi 2006 0.75
118 Gene expression profiling in apoptotic k562 cells treated by homoharringtonine. Acta Biochim Biophys Sin (Shanghai) 2007 0.75
119 [Intra-operative GeneSearch(TM) BLN assay for detecting breast cancer metastases in sentinel lymph nodes]. Zhonghua Yi Xue Za Zhi 2011 0.75
120 Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection. Clin Chem Lab Med 2016 0.75
121 A prospective comparison of molecular assay and touch imprint cytology for intraoperative evaluation of sentinel lymph nodes. Chin Med J (Engl) 2011 0.75
122 [Study on predictors of long term results for neo-adjuvant chemotherapy in locally advanced breast cancer]. Zhonghua Wai Ke Za Zhi 2009 0.75
123 [In vitro study of the effects of estrogen receptor beta expression on the biological behavior of a human breast cancer cell line]. Zhonghua Zhong Liu Za Zhi 2005 0.75
124 Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations. Breast Cancer Res Treat 2009 0.75
125 [Prospective multi-center study of one-step nucleic acid amplification assay for the detection of sentinel lymph nodes metastases in breast cancer patients]. Zhonghua Yi Xue Za Zhi 2013 0.75
126 [Effect of postoperative pregnancy upon prognosis of young breast cancer patients]. Zhonghua Yi Xue Za Zhi 2009 0.75
127 GeneSearch™ BLN Assay could replace frozen section and touch imprint cytology for intra-operative assessment of breast sentinel lymph nodes. Breast Cancer 2013 0.75
128 [Establishment and clinical application of liquid chromatography-tandem mass spectrometric method for simultaneous determination of plasma 5-fluorouracil]. Zhonghua Yi Xue Za Zhi 2016 0.75
129 [Expression of CK5/6 and CK17 and its correlation with prognosis of triple-negative breast cancer patients]. Zhonghua Zhong Liu Za Zhi 2008 0.75
130 [Evaluation of intraoperative touch imprint cytology of sentinel lymph node for breast cancer]. Zhonghua Zhong Liu Za Zhi 2007 0.75
131 Gene expression pattern in apoptotic QGY-7703 cells induced by homoharringtonine. Acta Pharmacol Sin 2007 0.75